Skip to content

Released Aug 9, 2022, after the close

10-Q filed Aug 9, 2022, 40 days after period end · 0001564590-22-028763

Q2 2022 · 10-Q
Revenue—
Net Income-$24.46MN/M vs Q2 2021N/M vs Q1 2022
EPS Diluted-$0.51N/M vs Q2 2021N/M vs Q1 2022
Operating Income-$24,573,000N/M
Operating Cash Flowderived-$17,885,000N/M
Free Cash Flowderived-$17,885,000N/M

What the release said

The release

Same quarter

MetricQ2 2022Q2 2021Q2 2020Q2 2019
Revenue——$39.38M$3.08M
Net Income-$24.46M-$23.60M$7.27M-$18.50M
EPS Diluted-$0.51-$0.55$0.19-$0.72

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR